At week 52, on active treatment, the odds of at least partial remission were lower for the MMF/dexamethasone group, but the difference did not reach statistical significance.
← all excerpts
Calcineurin Inhibitors in the Treatment of Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis of the Literature.
1
—
—